Identification of mannich base as a novel inhibitor of Mycobacterium Tuberculosis isocitrate by high-throughput screening

International Journal of Biological Sciences

Volumn 7, Issue 3, 2011, Pages 376-382

  Ji, Lei ^a   Long, Quanxin ^a   Yang, Dacheng ^a   Xie, Jianping ^a  

^a SOUTHWEST UNIVERSITY   (China)

Author keywords

Drug target; High throughput screening; Isocitrate lyase; Mannich bases; Mycobacterium tuberculosis

Indexed keywords

FUNGI; MYCOBACTERIUM TUBERCULOSIS;

EID: 79955528594     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.7.376     Document Type: Article

References (30)

1. Campbell J.J, Smith R.A, and Eagles B.A. A deviation from the conventional tricarboxylic acid cycle in Pseudomonas aeru-ginosa. Biochim Biophys Acta. 1953; 11: 594.
2. Kornberg H.L and Krebs H.A. Synthesis of cell constituents from C2-units by a modified tricarboxylic acid cycle. Nature. 1957; 179: 988-91.
3. Britton K, Langridge S, Baker P.J, et al. The crystal structure and active site location of isocitrate lyase from the fungus Asper-gillus nidulans. Structure. 2000; 8: 349-62.
4. McKinney J.D, Honer zu Bentrup K., Munoz-Elias E.J, et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature. 2000; 406: 735-8.
5. Kelly B.G, Wall D.M, Boland C.A, et al. Isocitrate lyase of the facultative intracellular pathogen Rhodococcus equi. Microbiology. 2002; 148: 793-8.
6. Lorenz M.C and Fink G.R. The glyoxylate cycle is required for fungal virulence. Nature. 2001; 412: 83-6.
7. Lorenz M.C and Fink G.R. Life and death in a macrophage: role of the glyoxylate cycle in virulence. Eukaryot Cell. 2002; 1: 657-62.
8. Floyd K, Blanc L, Raviglione M, et al. Resources required for global tuberculosis control. Science. 2002; 295: 2040-1.
9. WHO. Past, present and future of TB control. Geneva: WHO. 2005.
10. Sharma V, Sharma S, et al. Structure of isocitrate lyase, a per-sistence factor of Mycobacterium tuberculosis. Nat Struct Biol. 2000; 7: 663-8.
11. McKinney J.D. In vivo veritas: the search for TB drug targets goes live. Nat Med. 2000; 6: 1330-3.
12. Tramontini M and Angiolini L. Further advances in the chem-istry of mannich bases. Tetrahedron. 1990; 46: 1791-1837.
13. Dong J, Xu L, and Ji Z. Synthesis and antiinflammatory activity of 2-substituted cyclo-pentanone or 2-cyclopentenone Mannich bases from aromatic amines. Chin J Med Chem. 1998; 8: 5-9.
14. Chen H, Jing Y, Ji Z, et al. Synthesis and anti-inflammatory and anticancer activities of 2-(E)- (un)substituted benzylidene cy-clopentanones and their Mannich base hydro chlorides. Acta Pharm Sin. 1991; 26: 183-192.
15. El-Subbagh H.I, Abu-Zaid S.M, Mahran M.A, et al. Synthesis and biological evaluation of certain alpha,beta-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents. J Med Chem. 2000; 43: 2915-21.
16. Yang D, Fan L, Liu H, et al. A class of compounds that has the Mannich base stucture and its applications in the preparation of the treatment and/or prevention of leukemia drug. Chinese patent application No.200710092667.9. 2007.
17. Ma Y, Yin L, Liu Y, et al. Synthesis and antitumor activities of 2-(E)-(4-cyclo -pentyloxy -3-methyl-benzylidene) cyclopenta-none arylamine Mannich bases. Chin J Med Chem. 2006; 16: 144-149.
18. Kocabalkanli A, Ates O, and Otuk G. Synthesis of Mannich bases of some 2,5-disubstituted 4-thiazolidinones and evaluation of their antimicrobial activities. Arch Pharm (Weinheim). 2001; 334: 35-9.
19. Joshi S, Khosla N, Khare D, et al. Synthesis and in vitro study of novel Mannich bases as antibacterial agents. Bioorg Med Chem Lett. 2005; 15: 221-6.
20. Zhou C, Wu G, Feng Y, et al. Discovery and biological charac-terization of a novel series of androgen receptor modulators. Br J Pharmacol. 2008; 154: 440-50.
21. Song X, Yan J, Fan L, et al. Synthesis and Preliminary Evalua-tion of Antidiabetic Activity of 4-(1-Aryl-3-aryl/arylalkyl-3-oxopropylamino)-N-(5-methyl-3-isoxazolyl)benzene Sulfonamide. Chin J Org Chem. 2009; 29: 606-613.
22. Xu J, Yan J, Fan L, et al. Synthesis and α -glucosidase inhibitory activity of N-(1,5-diaryl-3-pentone-1-yl)-4-aminobenzoic acid. Acta Pharm Sin. 2009; 44: 48-55.
23. Yang D, Yan J, Fan L, et al. β-amino ketone derivatives for antidiabetic activity. Chinese patent application No. 200810237001.2. 2008.
24. Li Q, Yang D, Yan J, et al. A kind of new β-amino ke-tone/alcohol derivatives and its use. Chinese patent application No.200810148122.X. 2008.
25. Bai B, Xie J, Yan J, et al. A high throughput screening approach to identify isocitrate lyase inhibitors from traditional Chinese medicine sources. Drug Dev Res. 2006; 67: 818-823.
26. Graham F, Hatfull W.R.J. Molecular genetics of mycobacteria. ASM Press. 2000; 316.
27. Sambrook J, Fritsch E.F, and Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. 1989.
28. Dixon G.H and Kornberg H.L. Proceedings of the Biochemical Society. Biochem J. 1959; 72: 1P-13P.
29. Hanes C.S. Studies on plant amylases: The effect of starch con-centration upon the velocity of hydrolysis by the amylase of germinated barley. Biochem J. 1932; 26: 1406-21.
30. Zhang J.H, Chung T.D, and Oldenburg K.R. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen. 1999; 4: 67-73.